Skip to main content

Table 5 Candidate drugs targeting hub genes

From: Identification of candidate biomarkers and pathways associated with psoriasis using bioinformatics analysis

gene

drug

interaction_types

sources

pmids

CXCR2

PROPOFOL

agonist

GuideToPharmacologyInteractions

CXCR2

BENZPIPERYLON

agonist

GuideToPharmacologyInteractions

CXCR2

CHEMBL411250

agonist

GuideToPharmacologyInteractions

CXCR2

MEPHENTERMINE

agonist

GuideToPharmacologyInteractions

CXCR2

REPARIXIN

allosteric modulator|modulator|antagonist

GuideToPharmacologyInteractions|ChemblInteractions|TTD

CXCR2

DANIRIXIN

antagonist

GuideToPharmacologyInteractions|ChemblInteractions

CXCR2

NAVARIXIN

antagonist

GuideToPharmacologyInteractions|ChemblInteractions|TTD

CXCR2

CHEMBL239767

antagonist

GuideToPharmacologyInteractions

CXCR2

NAVARIXIN HYDRATE

antagonist

ChemblInteractions

CXCR2

ELUBRIXIN

antagonist

ChemblInteractions|TTD

CXCR2

Ladarixin

modulator

ChemblInteractions

CXCR2

BEVACIZUMAB

PharmGKB

CXCR2

CYCLOPHOSPHAMIDE

PharmGKB

CXCR2

ACETYLCYSTEINE

NCI

10,716,998

CXCR2

MECHLORETHAMINE HYDROCHLORIDE

NCI

12,753,603

CXCR2

VITAMIN E

NCI

16,679,868

CXCR2

GENISTEIN

NCI

9,712,063

ISG15

IRINOTECAN

inhibitor

MyCancerGenomeClinicalTrial

OASL

PEGINTERFERON ALFA-2B

PharmGKB

OASL

RIBAVIRIN

PharmGKB

IVL

ETRETINATE

NCI

12,445,200|8,381,448

IVL

RETINYL ACETATE

NCI

6,189,593

IVL

PERILLYL ALCOHOL

NCI

10,769,631

CXCL10

NI-0801

inhibitor

ChemblInteractions

CXCL10

METHYLPREDNISOLONE

NCI

17,220,550

CXCL10

TESTOSTERONE

NCI

9,681,518

CXCL10

REGRAMOSTIM

NCI

11,591,765

CXCL10

OXALIPLATIN

NCI

16,101,140

CXCL10

ANTIBIOTIC

NCI

10,634,213

CXCL10

ZIDOVUDINE

NCI

11,141,242

CXCL10

ATROPINE

NCI

15,315,164

CXCL10

ELDELUMAB

TdgClinicalTrial

CXCL10

STAVUDINE

NCI

11,141,242

CXCL10

GONADOTROPIN, CHORIONIC

NCI

15,590,984

CXCL10

RITONAVIR

NCI

11,141,242

CXCL10

ATORVASTATIN

NCI

10,559,511